ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NCI names Porter Novelli executive as director for strategic dissemination.

August 1, 2003

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

DCPC Board Cool Toward Moving Centers, Other Programs to New Division; Issue To NCAB May 26

May 15, 1987

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG

July 10, 1998

Chest X-Rays In BRCA Carriers May Increase Cancer Risk

July 28, 2006